These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5952697)

  • 21. Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome.
    Abdel Razek AA; Sadek AG; Gaballa G
    Acad Radiol; 2010 Jun; 17(6):779-83. PubMed ID: 20350826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
    Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
    Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sonography of the thyroid gland in surgery].
    Thaler W
    Zentralbl Chir; 1987; 112(5):280-4. PubMed ID: 3296556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The histological discovery of carcinomatous areas within toxic goitres. Two new cases].
    Chupin M; Beutter D; Monballais MF
    Nouv Presse Med; 1978 May; 7(21):1858. PubMed ID: 580961
    [No Abstract]   [Full Text] [Related]  

  • 26. [Association of generalized sarcoidosis and diffuse toxic goiter].
    Khachatrian EN; Borisova PK; Ametov AS; Daurov BI; Bondarenko VO; Ostrenskaia SV
    Probl Tuberk; 1994; (5):35-7. PubMed ID: 7870723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The surgical treatment of toxic goiter in middle-aged and elderly patients].
    Pavlovs'kyĭ MP; Syroïd OM; Kolomiĭtsev VI
    Klin Khir; 1999; (12):24-6. PubMed ID: 10800330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between intrathyroidal dendritic cells and humoral immune disorder in Graves' disease].
    Zhang HJ; Li DM; Gao DL; Zhang L; Cao J; Zhao ZH; Zhang YH; Xu L
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):122-4. PubMed ID: 15840225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthyroidism associated with histologic Hashimoto's thyroiditis.
    Fatourechi V; McConahey WM; Woolner LB
    Mayo Clin Proc; 1971 Oct; 46(10):682-9. PubMed ID: 5171000
    [No Abstract]   [Full Text] [Related]  

  • 30. IMAGES IN CLINICAL MEDICINE. Thyroid Ophthalmopathy, Dermopathy, and Acropachy.
    Guerrero C; Pittelkow MR
    N Engl J Med; 2016 Jul; 375(3):261. PubMed ID: 27468062
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of FDG uptake in bilateral thyroid glands.
    Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
    Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ectopic thyroid tissue and Graves' disease in an elderly patient.
    Mollar-Puchades MA; Merino-Torres JF; Segovia-Portolés R; Abellán-Galiana P; Gómez-Vela J; Piñón-Sellés F
    Thyroid; 2006 Jul; 16(7):701-2. PubMed ID: 16889496
    [No Abstract]   [Full Text] [Related]  

  • 35. [Surgical treatments in recurrent Graves' disease].
    Velikov M; Mendizov I; Dashev G
    Khirurgiia (Sofiia); 1998; 52(5):42-5. PubMed ID: 11247084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphoid infiltration of the thyroid gland and antithyroid antibodies in patients with diffuse toxic goiter].
    Ibragim MD; Bazarova EN; Bronshteĭn ME; Iur'eva NP; Konnova EV
    Probl Endokrinol (Mosk); 1985; 31(3):18-22. PubMed ID: 3903739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thyrotoxicosis and thyroid cancer].
    Kazeev KN; Bazarova EN; Babin AV; Bronshteĭn ME; Iur'eva NP
    Sov Med; 1980; (9):46-9. PubMed ID: 6893500
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
    Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
    Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of Graves disease after 40 years.
    Modi KD; Sharma A; Mishra SK
    J Assoc Physicians India; 1994 Jun; 42(6):507. PubMed ID: 7852245
    [No Abstract]   [Full Text] [Related]  

  • 40. [Special functional diagnosis and therapy of malignant goiter].
    Becker T; Correns HJ; Schmidt K
    Zentralbl Chir; 1965; 90(26):1280-91. PubMed ID: 5899070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.